【24h】

HA-decorated nanoparticles as tumour-targeting nucleic acids carriers

机译:HA装饰的纳米颗粒作为靶向肿瘤的核酸载体

获取原文

摘要

In the context of nucleic acids delivery, an ideal carrier should not only provide the means for the transport of such payloads, but also protect their activity by limiting their exposure to harmful agents leading to either physical or enzymatic degradation. We here report on the development of nanoparticles designed to target CD44; which is a membrane protein overexpressed in many tumours, while also being the major receptor of hyaluronic acid (HA). The herein described particles present a chitosan (CS) core for nucleic acids complexation and a surface rich in HA. Nanoparticles CD44-HA mediated endocytic process, and the intracellular localisation of nucleic acids and their effects were observed using fluorescently labeled nanoparticle components. Sections and 3D reconstructions of the target (HT-29, colorectal cancer cells) and off-target (THP-1 macrophages) CD44-expressing cells were registered at different time points.
机译:在核酸递送的背景下,理想的载体不仅应提供运输此类有效载荷的手段,而且还应通过限制其暴露于导致物理或酶促降解的有害物质而保护其活性。我们在这里报告了旨在靶向CD44的纳米颗粒的发展。它是在许多肿瘤中过表达的膜蛋白,同时也是透明质酸(HA)的主要受体。本文描述的颗粒具有用于核酸复合的壳聚糖(CS)核心和富含HA的表面。使用荧光标记的纳米颗粒组分观察到纳米颗粒CD44-HA介导的内吞过程,以及核酸在细胞内的定位及其作用。在不同的时间点记录了目标(HT-29,结直肠癌细胞)和脱靶(THP-1巨噬细胞)CD44表达细胞的切片和3D重建。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号